Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada.
Orbit. 2022 Feb;41(1):84-88. doi: 10.1080/01676830.2020.1841808. Epub 2020 Nov 5.
To determine the effect of epinephrine as an anesthetic adjunct on outcomes of conjunctival-Müller's muscle resection (CMMR) ptosis surgery.
A retrospective cohort study of patients having undergone CMMR with plain local anesthetic (LA) and local anesthetic combined with epinephrine (LA+Epi). Two measures of success were investigated: margin to reflex distance 1 (MRD1) success and overall success. MRD1 success was defined as a postoperative MRD1 between 2-4 mm. Overall success was defined as all of i) MRD1 success, ii) a ≤ 1 mm difference between the eyelid height following the preoperative phenylephrine test and post-operative MRD1 (PE-MRD1 Δ), and iii) symmetrical postoperative contour between both upper eyelids. Study inclusion criteria included blepharoptosis from levator aponeurotic dehiscence and satisfactory response to the phenylephrine test. Exclusion criteria included congenital ptosis, ptosis secondary to another cause, previous ipsilateral eyelid surgery, or a medical condition that may have impacted surgery.
There were 26 eyelids in the LA+Epi group, and 19 eyelids in the LA group. There was no difference in the two groups in age (P =0.28), pre-operative MRD1 (P =0.37), levator function (P =0.27), intraoperative tissue resection amount (P =0.27), number of weeks postoperatively at final MRD1 measurement (P =0.99), and PE-MRD1 Δ (P =0.08). All patients achieved a symmetrical post-operative eyelid contour. The LA+Epi group had a higher attainment of MRD1 success (P =0.04) and overall success (P =0.045).
Epinephrine as an anesthetic adjunct improves CMMR outcome. This suggests its use can be considered the standard of care.
确定肾上腺素作为麻醉辅助剂对结膜-Müller 肌切除术(CMMR)上睑下垂手术结果的影响。
这是一项回顾性队列研究,纳入了接受单纯局部麻醉(LA)和局部麻醉联合肾上腺素(LA+Epi)的 CMMR 患者。研究调查了两种成功衡量标准:MRD1 成功和总体成功。MRD1 成功定义为术后 MRD1 为 2-4mm。总体成功定义为所有以下 i)MRD1 成功,ii)术前苯肾上腺素测试后和术后 MRD1(PE-MRD1Δ)之间的睑裂高度差异≤1mm,以及 iii)双侧上睑术后轮廓对称。研究纳入标准包括因提上睑肌腱膜断裂引起的上睑下垂和对苯肾上腺素测试有满意反应。排除标准包括先天性上睑下垂、由其他原因引起的上睑下垂、同侧眼睑手术史或可能影响手术的其他疾病。
LA+Epi 组有 26 只眼睑,LA 组有 19 只眼睑。两组在年龄(P=0.28)、术前 MRD1(P=0.37)、提上睑肌功能(P=0.27)、术中组织切除量(P=0.27)、最终 MRD1 测量时术后周数(P=0.99)和 PE-MRD1Δ(P=0.08)方面均无差异。所有患者术后睑裂轮廓均对称。LA+Epi 组的 MRD1 成功率(P=0.04)和总体成功率(P=0.045)更高。
肾上腺素作为麻醉辅助剂可改善 CMMR 手术结果。这表明其应用可作为标准治疗方案。